Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.

× No keyword cloud information.

14 in total

1. Finasteride for chronic central serous chorioretinopathy.

Authors: Farzin Forooghian; Annal D Meleth; Catherine Cukras; Emily Y Chew; Wai T Wong; Catherine B Meyerle
Journal: Retina Date: 2011-04 Impact factor: 4.256

2. Alterations in "in vivo" histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab.

Authors: Sandeep Saxena; Astha Jain
Journal: J Ocul Biol Dis Infor Date: 2012-03-08

3. Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors: Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal: Trans Am Ophthalmol Soc Date: 2015

4. Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.

Authors: G A Kim; T H Rim; S C Lee; S H Byeon; H J Koh; S S Kim; C S Lee
Journal: Eye (Lond) Date: 2015-05-08 Impact factor: 3.775

5. Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy.

Authors: Yoo-Ri Chung; Su Jeong Lee; Ji Hun Song
Journal: J Clin Med Date: 2022-06-13 Impact factor: 4.964

6. Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.

Authors: S H Lim; W Chang; M Sagong
Journal: Eye (Lond) Date: 2013-03-01 Impact factor: 3.775

7. Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy.

Authors: Francesco Semeraro; Mario R Romano; Paola Danzi; Francesco Morescalchi; Ciro Costagliola
Journal: Jpn J Ophthalmol Date: 2012-08-23 Impact factor: 2.447

8. Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy.

Authors: Pedro Cuevas; Luis A Outeiriño; Carlos Azanza; Javier Angulo; Guillermo Giménez-Gallego
Journal: Eur J Med Res Date: 2012-07-12 Impact factor: 2.175

9. The association between choroidal thickness variations and response to intravitreal bevacizumab in central serous chorioretinopathy.

Authors: Dong Yoon Kim; Soo Geun Joe; Sung Jae Yang; Joo Yong Lee; June-Gone Kim; Young Hee Yoon
Journal: Korean J Ophthalmol Date: 2015-05-20

10. Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy.

Authors: Aditya Kelkar; Poonam Gandhi; Winfried Amoaku; Jai Kelkar; Shreekant Kelkar; Priyanka Raut; Rachana Shah
Journal: Case Rep Ophthalmol Date: 2014-07-11